What does Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. do?

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 603168.SS's market cap?

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS) has a market capitalization of approximately $2.18 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 603168.SS pay a dividend?

Yes — Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

Is 603168.SS profitable?

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

603168.SS

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

SHH·Medical, Pharmaceuticals · Healthcare

¥5.84¥0.08+1.39%

Market cap¥2.18B·Aug 26 7:00 AM UTC

Price Chart

¥5.84+¥0.08 (+1.39%)today

−41.19%CAGR −10.07%

Select date range

FromTo

Jul 2, 2014Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.00%

Annual Dividend (FWD)¥0.00

Dividend Growth (5Y)−32.9%

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent Dividend¥0.021

Ex-Dividend DateJun 13

Payment DateJun 13

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateApr 29

Last Report DateSep 29

Reported vs Estimate¥0.02

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥459.57M

Net Income−¥273.68M

Net Margin−59.6%

Operating Cash Flow¥26.49M

Capital Expenditures¥107.25M

Free Cash Flow−¥80.76M

Return on Equity−20.7%

Return on Invested Capital−1.6%

Net Debt¥145.81M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 603168.SS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 603168.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 603168.SS and 80,000+ other tickers.

About Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes. It offers its products in injections, oral solutions, eye drops, large-volume injections, oral solutions, tablets, granules, and other dosage forms. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was founded in 2000 and is based in Pinghu, China.

CEO: Hong Li Lin
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Exchange: SHH
Employees: 1,142
Website: www.zjspas.com

Peers

Peers Tab

000590.SZ

Guhan Pharmaceutical Group Co., Ltd.

Cap

¥2.3B

600080.SS

Ginwa Enterprise (Group) Inc.

Cap

¥1.8B

300534.SZ

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

Cap

¥5.2B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 603168.SS

What does Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. do?: Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 603168.SS's market cap?: Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS) has a market capitalization of approximately $2.18 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 603168.SS pay a dividend?: Yes — Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.
Is 603168.SS profitable?: Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.